WHAT IS PASH.TM?
The Peer Advocacy Network for the Sexual Health of Trans Masculinities (PASH.tm) is an autonomous and national working group committed to addressing the sexual health needs of gay, bisexual and queer trans men and other trans masculine people assigned female at birth (trans MSM).
PASH.tm was formed as a result of the first ever trans networking zone at the International AIDS Conference, ‘AIDS2014’, held in Melbourne Australia during July 2014. Four trans guys from across Australia got to talking and that turned into the establishment of PASH.tm. There are now six of us on the working group.
With the support of the Australian Federation of AIDS Organisations (AFAO) and its members, we have continued to build momentum. Since establishment, PASH.tm has presented workshops at major national HIV and STI conferences, presented to HIV and STI action groups and networks.
We have also released position statements on best practice data collection recommendations and on PrEP, submitted recommendations for the NSW and national PrEP access guidelines; the review of the NSW Public Health Act; and the PBS listing of Truvada™ as PrEP, and have now produced Grunt.
Who are we?
We are gay, bi and queer trans men and trans masculine people assigned female at birth with a diverse range of backgrounds spanning across grass roots activism, community organising, health promotion, HIV education, HIV activism, community development, policy, advocacy, project management, public health, resource development, sexual health, alcohol and drugs, media, youth and social work.
What do we believe in?
PASH.tm believes that advocacy, research and health promotion is best served through community engagement and peer-led programs. PASH.tm operates from a space that honours sex positivity, and we work from and contribute to a growing evidence base.
Why is PASH.tm important?
Trans MSM are not identified as a priority population and are largely overlooked when it comes to sexual health promotion and HIV prevention in Australia and globally. There is limited global and local research about the sexual and risk behaviours of trans men who have sex with cis men, but what we do know is that trans men aren’t targeted with sexual health messaging, risk and harm reduction strategies or actively included in vital research or medical trials which focus on men who have sex with other men. Research also indicates worryingly low rates of HIV and STI testing in all trans masculine populations and an emerging HIV epidemic among trans men who have sex with cis men. This is why we are here.